Cytek Biosciences, Inc. · NASDAQ:CTKB
Cytek Biosciences, Inc. shareholders
As of Jun 30, 2026, 150 institutions reported holding Cytek Biosciences, Inc., 62.7% of its shares. Largest: BlackRock, Millennium and Boston Partners. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cytek Biosciences, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 9.58M | 7.4% | −7.43M | Aug 7, 2026 |
| Millennium | 9.34M | 7.2% | +3.05M | Aug 14, 2026 |
| Boston Partners | 7.66M | 5.9% | +1.86M | Aug 4, 2026 |
| Vanguard | 6.87M | 5.3% | −970K | Aug 13, 2026 |
| Hhlr Advisors, LTD. | 6.66M | 5.1% | held for review | Aug 14, 2026 |
| Topline Capital Management, LLC | 6.28M | 4.8% | held for review | Aug 14, 2026 |
| Geode Capital | 3.06M | 2.4% | +226K | Aug 12, 2026 |
| Dimensional | 2.62M | 2.0% | −47,072 | Aug 11, 2026 |
| State Street | 2.57M | 2.0% | −1.56M | Aug 7, 2026 |
| Goldman Sachs | 2.17M | 1.7% | −177K | Aug 14, 2026 |